pubmed-article:21753896 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:21753896 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:21753896 | lifeskim:mentions | umls-concept:C0022104 | lld:lifeskim |
pubmed-article:21753896 | lifeskim:mentions | umls-concept:C0127615 | lld:lifeskim |
pubmed-article:21753896 | lifeskim:mentions | umls-concept:C0543482 | lld:lifeskim |
pubmed-article:21753896 | lifeskim:mentions | umls-concept:C0205210 | lld:lifeskim |
pubmed-article:21753896 | pubmed:dateCreated | 2011-7-14 | lld:pubmed |
pubmed-article:21753896 | pubmed:abstractText | The aim of this study was to analyze the clinical efficacy and cytomorphologic changes of colon mucosa following the treatment of patients suffering from irritable bowel syndrome (IBS) with mesalazine (5-aminosalicylic acid [5-ASA]). | lld:pubmed |
pubmed-article:21753896 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21753896 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21753896 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21753896 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21753896 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21753896 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21753896 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21753896 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21753896 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21753896 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21753896 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21753896 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21753896 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21753896 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21753896 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21753896 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21753896 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21753896 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21753896 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21753896 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21753896 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21753896 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21753896 | pubmed:language | eng | lld:pubmed |
pubmed-article:21753896 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21753896 | pubmed:status | PubMed-not-MEDLINE | lld:pubmed |
pubmed-article:21753896 | pubmed:issn | 1178-7023 | lld:pubmed |
pubmed-article:21753896 | pubmed:author | pubmed-author:DorofeyevAndr... | lld:pubmed |
pubmed-article:21753896 | pubmed:author | pubmed-author:KiriyanElena... | lld:pubmed |
pubmed-article:21753896 | pubmed:author | pubmed-author:VasilenkoInna... | lld:pubmed |
pubmed-article:21753896 | pubmed:author | pubmed-author:RassokhinaOlg... | lld:pubmed |
pubmed-article:21753896 | pubmed:author | pubmed-author:ElinAndrey... | lld:pubmed |
pubmed-article:21753896 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:21753896 | pubmed:volume | 4 | lld:pubmed |
pubmed-article:21753896 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:21753896 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:21753896 | pubmed:pagination | 141-53 | lld:pubmed |
pubmed-article:21753896 | pubmed:dateRevised | 2011-8-1 | lld:pubmed |
pubmed-article:21753896 | pubmed:year | 2011 | lld:pubmed |
pubmed-article:21753896 | pubmed:articleTitle | Clinical, endoscopical and morphological efficacy of mesalazine in patients with irritable bowel syndrome. | lld:pubmed |
pubmed-article:21753896 | pubmed:affiliation | National Medical University, Donetsk, Ukraine; | lld:pubmed |
pubmed-article:21753896 | pubmed:publicationType | Journal Article | lld:pubmed |